Dr. Bruce Imbert is an entrepreneurial physician executive with over 20 years in the healthcare industry and over 15 years of clinical and strategic leadership in CNS therapeutics, specializing in addiction, psychiatry, and digital therapeutics. He has a proven track record in leading clinical development, securing non-dilutive funding, and navigating complex regulatory environments for groundbreaking therapeutics.Dr. Imbert is passionate about advancing treatments for substance use disorders and psychiatric conditions through innovation and collaboration. His expertise spans CNS therapeutics, digital health solutions, regulatory strategy, and early-to-late-stage clinical development, with a focus on patient-centered solutions.Having successfully led multiple clinical programs, Dr. Imbert brings deep experience in drug development from Phase I through commercialization. He has clinical development experience in numerous indications, including substance use disorders, schizophrenia, major depression, anxiety disorders, and ADHD. He has worked across diverse therapeutic modalities, including intranasal sprays, long-acting injectables, and oral formulations, with significant expertise in the psychedelic space, particularly in assessing scientific approaches and clinical development programs.In his pharmaceutical leadership roles, Dr. Imbert has gained extensive experience in global clinical development, regulatory submissions, and medical governance. He forges strategic partnerships that drive research, commercialization, and secure funding to support innovation.As part of his contributions to the field, Dr. Imbert was invited by the NIH Director to serve as a Member of the Medication Development Research Study Section within the National Institute on Drug Abuse (NIDA) Initial Review Group, where he collaborates on advancing treatments for substance use disorders and psychiatric comorbidities. He was also appointed by the French Minister of Social Affairs and Health to the National Commission of First Instance for the validation of competences in addiction medicine.As a cross-functional leader, Dr. Imbert brings a multicultural background and a unique perspective, making him adaptable and resourceful in problem-solving.Areas of expertise include:Clinical Development Strategy, CNS Therapeutics, Addiction & Psychiatry, Regulatory Submissions, Digital Health & Digital Therapeutics, Real-World Evidence, Translational Medicine, Non-Dilutive Funding, Lifecycle Management, Risk Management & Strategic Partnerships.